<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1987-08-13" modified="2020-10-07" version="159">
<accession>P68403</accession>
<accession>P04410</accession>
<accession>P04411</accession>
<name>KPCB_RAT</name>
<protein>
<recommendedName>
<fullName>Protein kinase C beta type</fullName>
<shortName>PKC-B</shortName>
<shortName>PKC-beta</shortName>
<ecNumber>2.7.11.13</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">Prkcb</name>
<name type="synonym">Pkcb</name>
<name type="synonym">Prkcb1</name>
</gene>
<organism>
<name type="scientific">Rattus norvegicus</name>
<name type="common">Rat</name>
<dbReference type="NCBI Taxonomy" id="10116"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Rattus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Cell" volume="46" first="491" last="502">
<title>Cloning and expression of multiple protein kinase C cDNAs.</title>
<authorList>
<person name="Knopf J.L."/>
<person name="Lee M.-H."/>
<person name="Sultzman L.A."/>
<person name="Kriz R.W."/>
<person name="Loomis C.R."/>
<person name="Hewick R.M."/>
<person name="Bell R.M."/>
</authorList>
<dbReference type="PubMed" id="3755379"/>
<dbReference type="DOI" id="10.1016/0092-8674(86)90874-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS BETA-I AND BETA-II)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1986" name="FEBS Lett." volume="206" first="347" last="352">
<title>Two types of complementary DNAs of rat brain protein kinase C. Heterogeneity determined by alternative splicing.</title>
<authorList>
<person name="Ono Y."/>
<person name="Kurokawa T."/>
<person name="Fujii T."/>
<person name="Kawahara K."/>
<person name="Igarashi K."/>
<person name="Kikkawa U."/>
<person name="Ogita K."/>
<person name="Nishizuka Y."/>
</authorList>
<dbReference type="PubMed" id="2428667"/>
<dbReference type="DOI" id="10.1016/0014-5793(86)81010-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS BETA-I AND BETA-II)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1988" name="Cell" volume="52" first="343" last="354">
<title>Overproduction of protein kinase C causes disordered growth control in rat fibroblasts.</title>
<authorList>
<person name="Housey G.M."/>
<person name="Johnson M.D."/>
<person name="Hsiao W.L.W."/>
<person name="O'Brian C.A."/>
<person name="Murphy J.P."/>
<person name="Kirschmeier P."/>
<person name="Weinstein I.B."/>
</authorList>
<dbReference type="PubMed" id="3345563"/>
<dbReference type="DOI" id="10.1016/s0092-8674(88)80027-8"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-I)</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1986" name="FEBS Lett." volume="203" first="111" last="115">
<title>Cloning of rat brain protein kinase C complementary DNA.</title>
<authorList>
<person name="Ono Y."/>
<person name="Kurokawa T."/>
<person name="Kawahara K."/>
<person name="Nishimura O."/>
<person name="Marumoto R."/>
<person name="Igarashi K."/>
<person name="Sugino Y."/>
<person name="Kikkawa U."/>
<person name="Ogita K."/>
<person name="Nishizuka Y."/>
</authorList>
<dbReference type="PubMed" id="3755404"/>
<dbReference type="DOI" id="10.1016/0014-5793(86)80724-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 448-671 (ISOFORM BETA-I)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="1065" last="1069">
<title>Isolation of cDNA clones encoding protein kinase C: evidence for a protein kinase C-related gene family.</title>
<authorList>
<person name="Housey G.M."/>
<person name="O'Brian C.A."/>
<person name="Johnson M.D."/>
<person name="Kirschmeier P."/>
<person name="Weinstein I.B."/>
</authorList>
<dbReference type="PubMed" id="3469647"/>
<dbReference type="DOI" id="10.1073/pnas.84.4.1065"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 448-671 (ISOFORM BETA-I)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1995" name="Curr. Biol." volume="5" first="1394" last="1403">
<title>Protein kinase C is regulated in vivo by three functionally distinct phosphorylations.</title>
<authorList>
<person name="Keranen L.M."/>
<person name="Dutil E.M."/>
<person name="Newton A.C."/>
</authorList>
<dbReference type="PubMed" id="8749392"/>
<dbReference type="DOI" id="10.1016/s0960-9822(95)00277-6"/>
</citation>
<scope>PROTEIN SEQUENCE OF 500-520 AND 636-663 (ISOFORM BETA-II)</scope>
<scope>PHOSPHORYLATION AT THR-500; THR-642 AND SER-661</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="6130" last="6134">
<title>Characterization of site-specific mutants altered at protein kinase C beta 1 isozyme autophosphorylation sites.</title>
<authorList>
<person name="Zhang J."/>
<person name="Wang L."/>
<person name="Petrin J."/>
<person name="Bishop W.R."/>
<person name="Bond R.W."/>
</authorList>
<dbReference type="PubMed" id="8327493"/>
<dbReference type="DOI" id="10.1073/pnas.90.13.6130"/>
</citation>
<scope>PHOSPHORYLATION AT SER-16; THR-17; THR-314; THR-324; THR-635 AND THR-642</scope>
<scope>MUTAGENESIS OF 16-SER-THR-17; THR-314; THR-324; THR-635 AND THR-642</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="19578" last="19584">
<title>Phosphorylation of Thr642 is an early event in the processing of newly synthesized protein kinase C beta 1 and is essential for its activation.</title>
<authorList>
<person name="Zhang J."/>
<person name="Wang L."/>
<person name="Schwartz J."/>
<person name="Bond R.W."/>
<person name="Bishop W.R."/>
</authorList>
<dbReference type="PubMed" id="8034726"/>
</citation>
<scope>PHOSPHORYLATION AT THR-642 (ISOFORM BETA-I)</scope>
<scope>MUTAGENESIS OF THR-635 AND THR-642</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="27715" last="27718">
<title>Requirement for negative charge on 'activation loop' of protein kinase C.</title>
<authorList>
<person name="Orr J.W."/>
<person name="Newton A.C."/>
</authorList>
<dbReference type="PubMed" id="7961692"/>
</citation>
<scope>PHOSPHORYLATION AT THR-500</scope>
<scope>MUTAGENESIS OF THR-500</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="6323" last="6333">
<title>Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells.</title>
<authorList>
<person name="Formisano P."/>
<person name="Oriente F."/>
<person name="Fiory F."/>
<person name="Caruso M."/>
<person name="Miele C."/>
<person name="Maitan M.A."/>
<person name="Andreozzi F."/>
<person name="Vigliotta G."/>
<person name="Condorelli G."/>
<person name="Beguinot F."/>
</authorList>
<dbReference type="PubMed" id="10938109"/>
<dbReference type="DOI" id="10.1128/mcb.20.17.6323-6333.2000"/>
</citation>
<scope>FUNCTION IN INSULIN SIGNALING</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="3680" last="3685">
<title>Involvement of protein kinase C beta 2 in c-myc induction by high glucose in pancreatic beta-cells.</title>
<authorList>
<person name="Kaneto H."/>
<person name="Suzuma K."/>
<person name="Sharma A."/>
<person name="Bonner-Weir S."/>
<person name="King G.L."/>
<person name="Weir G.C."/>
</authorList>
<dbReference type="PubMed" id="11714718"/>
<dbReference type="DOI" id="10.1074/jbc.m109647200"/>
</citation>
<scope>FUNCTION IN INSULIN SIGNALING</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="8567" last="8581">
<title>Phosphorylation of activation transcription factor-2 at serine 121 by protein kinase c controls c-Jun-mediated activation of transcription.</title>
<authorList>
<person name="Yamasaki T."/>
<person name="Takahashi A."/>
<person name="Pan J."/>
<person name="Yamaguchi N."/>
<person name="Yokoyama K.K."/>
</authorList>
<dbReference type="PubMed" id="19176525"/>
<dbReference type="DOI" id="10.1074/jbc.m808719200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2012" name="Nat. Commun." volume="3" first="876" last="876">
<title>Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues.</title>
<authorList>
<person name="Lundby A."/>
<person name="Secher A."/>
<person name="Lage K."/>
<person name="Nordsborg N.B."/>
<person name="Dmytriyev A."/>
<person name="Lundby C."/>
<person name="Olsen J.V."/>
</authorList>
<dbReference type="PubMed" id="22673903"/>
<dbReference type="DOI" id="10.1038/ncomms1871"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11 AND THR-642</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-641; SER-654; SER-660 AND SER-664 (ISOFORM BETA-II)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1998" name="Structure" volume="6" first="1395" last="1405">
<title>Structure of the protein kinase Cbeta phospholipid-binding C2 domain complexed with Ca2+.</title>
<authorList>
<person name="Sutton R.B."/>
<person name="Sprang S.R."/>
</authorList>
<dbReference type="PubMed" id="9817842"/>
<dbReference type="DOI" id="10.1016/s0969-2126(98)00139-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 157-288 IN COMPLEX WITH CALCIUM IONS</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Cell" volume="144" first="55" last="66">
<title>Crystal structure and allosteric activation of protein kinase C betaII.</title>
<authorList>
<person name="Leonard T.A."/>
<person name="Rozycki B."/>
<person name="Saidi L.F."/>
<person name="Hummer G."/>
<person name="Hurley J.H."/>
</authorList>
<dbReference type="PubMed" id="21215369"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.12.013"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (4.00 ANGSTROMS) OF 1-661 IN COMPLEX WITH CALCIUM IONS</scope>
<scope>COFACTOR</scope>
<scope>PHOSPHORYLATION AT THR-500; THR-642 AND SER-661</scope>
</reference>
<comment type="function">
<text evidence="4 5 11 12 13">Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-652'. Phosphorylation induces CARD11/CARMA1 association with lipid rafts and recruitment of the BCL10-MALT1 complex as well as MAP3K7/TAK1, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. Plays a direct role in the negative feedback regulation of the BCR signaling, by down-modulating BTK function via direct phosphorylation of BTK at 'Ser-180', which results in the alteration of BTK plasma membrane localization and in turn inhibition of BTK activity. Involved in apoptosis following oxidative damage: in case of oxidative conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to mitochondrial accumulation of p66Shc, where p66Shc acts as a reactive oxygen species producer. Acts as a coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag for epigenetic transcriptional activation that prevents demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A. In insulin signaling, may function downstream of IRS1 in muscle cells and mediate insulin-dependent DNA synthesis through the RAF1-MAPK/ERK signaling cascade. Participates in the regulation of glucose transport in adipocytes by negatively modulating the insulin-stimulated translocation of the glucose transporter SLC2A4/GLUT4. Phosphorylates SLC2A1/GLUT1, promoting glucose uptake by SLC2A1/GLUT1. Under high glucose in pancreatic beta-cells, is probably involved in the inhibition of the insulin gene transcription, via regulation of MYC expression. In endothelial cells, activation of PRKCB induces increased phosphorylation of RB1, increased VEGFA-induced cell proliferation, and inhibits PI3K/AKT-dependent nitric oxide synthase (NOS3/eNOS) regulation by insulin, which causes endothelial dysfunction. Also involved in triglyceride homeostasis (By similarity). Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription.</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]</text>
<dbReference type="Rhea" id="RHEA:17989"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:11604"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:83421"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.13"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction>
<text>ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:46608"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:11605"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:61977"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.13"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="6 14 19">
<name>Ca(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29108"/>
</cofactor>
<text evidence="14 19">Binds 3 Ca(2+) ions per subunit. The ions are bound to the C2 domain.</text>
</comment>
<comment type="activity regulation">
<text evidence="3">Classical (or conventional) PKCs (PRKCA, PRKCB and PRKCG) are activated by calcium and diacylglycerol (DAG) in the presence of phosphatidylserine. Three specific sites; Thr-500 (activation loop of the kinase domain), Thr-642 (turn motif) and Ser-661 (hydrophobic region), need to be phosphorylated for its full activation. Specifically inhibited by enzastaurin (LY317615) (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="3">Interacts with PDK1. Interacts in vitro with PRKCBP1. Interacts with PHLPP1 and PHLPP2; both proteins mediate its dephosphorylation. Interacts with KDM1A/LSD1, PKN1 and ANDR (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-397072">
<id>P68403</id>
</interactant>
<interactant intactId="EBI-6597520">
<id>P18052</id>
<label>Ptpra</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12559950">
<id>P68403-1</id>
</interactant>
<interactant intactId="EBI-918433">
<id>Q62920</id>
<label>Pdlim5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-397092">
<id>P68403-2</id>
</interactant>
<interactant intactId="EBI-726015">
<id>Q8WV44-2</id>
<label>TRIM41</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P68403-1</id>
<id>P04410-1</id>
<name>Beta-I</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P68403-2</id>
<id>P04410-2</id>
<name>Beta-II</name>
<sequence type="described" ref="VSP_004739"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="14 15 17 18">Phosphorylation on Thr-500 of isoform beta-I, within the activation loop, renders it competent to autophosphorylate. Subsequent autophosphorylation of Thr-642 maintains catalytic competence, and autophosphorylation on Ser-661 appears to release the kinase into the cytosol. Similarly, isoform beta-II is autophosphorylated on 'Thr-641' and 'Ser-660', subsequent to phosphorylation on Thr-500. Autophosphorylated on other sites i.e. in the N-terminal and hinge regions have no effect on enzyme activity. Phosphorylation at Tyr-662 by SYK induces binding with GRB2 and contributes to the activation of MAPK/ERK signaling cascade.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.</text>
</comment>
<dbReference type="EC" id="2.7.11.13"/>
<dbReference type="EMBL" id="M13706">
<property type="protein sequence ID" value="AAA41875.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="K03485">
<property type="protein sequence ID" value="AAA41864.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="K03486">
<property type="protein sequence ID" value="AAA41865.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X04439">
<property type="protein sequence ID" value="CAA28035.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X04440">
<property type="protein sequence ID" value="CAA28036.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M19007">
<property type="protein sequence ID" value="AAA41868.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X04139">
<property type="protein sequence ID" value="CAA27756.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M15522">
<property type="protein sequence ID" value="AAA41876.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PIR" id="A00622">
<property type="entry name" value="KIRTC1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001165776.1">
<property type="nucleotide sequence ID" value="NM_001172305.1"/>
</dbReference>
<dbReference type="PDB" id="1A25">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=154-289"/>
</dbReference>
<dbReference type="PDB" id="3PFQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A=1-661"/>
</dbReference>
<dbReference type="PDBsum" id="1A25"/>
<dbReference type="PDBsum" id="3PFQ"/>
<dbReference type="SMR" id="P68403"/>
<dbReference type="BioGRID" id="247103">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="IntAct" id="P68403">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="MINT" id="P68403"/>
<dbReference type="STRING" id="10116.ENSRNOP00000016417"/>
<dbReference type="BindingDB" id="P68403"/>
<dbReference type="ChEMBL" id="CHEMBL3020"/>
<dbReference type="DrugCentral" id="P68403"/>
<dbReference type="iPTMnet" id="P68403"/>
<dbReference type="jPOST" id="P68403"/>
<dbReference type="PaxDb" id="P68403"/>
<dbReference type="PRIDE" id="P68403"/>
<dbReference type="GeneID" id="25023"/>
<dbReference type="KEGG" id="rno:25023"/>
<dbReference type="UCSC" id="RGD:3396">
<property type="organism name" value="rat"/>
</dbReference>
<dbReference type="CTD" id="5579"/>
<dbReference type="RGD" id="3396">
<property type="gene designation" value="Prkcb"/>
</dbReference>
<dbReference type="eggNOG" id="KOG0696">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="InParanoid" id="P68403"/>
<dbReference type="KO" id="K19662"/>
<dbReference type="OrthoDB" id="614710at2759"/>
<dbReference type="PhylomeDB" id="P68403"/>
<dbReference type="Reactome" id="R-RNO-114516">
<property type="pathway name" value="Disinhibition of SNARE formation"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-1169091">
<property type="pathway name" value="Activation of NF-kappaB in B cells"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-416993">
<property type="pathway name" value="Trafficking of GluR2-containing AMPA receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-4419969">
<property type="pathway name" value="Depolymerisation of the Nuclear Lamina"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-5099900">
<property type="pathway name" value="WNT5A-dependent internalization of FZD4"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-5218921">
<property type="pathway name" value="VEGFR2 mediated cell proliferation"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-5668599">
<property type="pathway name" value="RHO GTPases Activate NADPH Oxidases"/>
</dbReference>
<dbReference type="Reactome" id="R-RNO-76005">
<property type="pathway name" value="Response to elevated platelet cytosolic Ca2+"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P68403"/>
<dbReference type="PRO" id="PR:P68403"/>
<dbReference type="Proteomes" id="UP000002494">
<property type="component" value="Unplaced"/>
</dbReference>
<dbReference type="GO" id="GO:0031526">
<property type="term" value="C:brush border membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0044305">
<property type="term" value="C:calyx of Held"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0099523">
<property type="term" value="C:presynaptic cytosol"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0008091">
<property type="term" value="C:spectrin"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0050681">
<property type="term" value="F:androgen receptor binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005246">
<property type="term" value="F:calcium channel regulator activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0004698">
<property type="term" value="F:calcium-dependent protein kinase C activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035403">
<property type="term" value="F:histone kinase activity (H3-T6 specific)"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030374">
<property type="term" value="F:nuclear receptor transcription coactivator activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004697">
<property type="term" value="F:protein kinase C activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0005080">
<property type="term" value="F:protein kinase C binding"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042113">
<property type="term" value="P:B cell activation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050853">
<property type="term" value="P:B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006816">
<property type="term" value="P:calcium ion transport"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006874">
<property type="term" value="P:cellular calcium ion homeostasis"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0071322">
<property type="term" value="P:cellular response to carbohydrate stimulus"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0018894">
<property type="term" value="P:dibenzo-p-dioxin metabolic process"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0035408">
<property type="term" value="P:histone H3-T6 phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010829">
<property type="term" value="P:negative regulation of glucose transmembrane transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046627">
<property type="term" value="P:negative regulation of insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050861">
<property type="term" value="P:positive regulation of B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042488">
<property type="term" value="P:positive regulation of odontogenesis of dentin-containing tooth"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0030949">
<property type="term" value="P:positive regulation of vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099171">
<property type="term" value="P:presynaptic modulation of chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0014059">
<property type="term" value="P:regulation of dopamine secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0010827">
<property type="term" value="P:regulation of glucose transmembrane transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0040008">
<property type="term" value="P:regulation of growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:2000300">
<property type="term" value="P:regulation of synaptic vesicle exocytosis"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0009749">
<property type="term" value="P:response to glucose"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="GO" id="GO:0033280">
<property type="term" value="P:response to vitamin D"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="RGD"/>
</dbReference>
<dbReference type="CDD" id="cd00029">
<property type="entry name" value="C1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="CDD" id="cd05616">
<property type="entry name" value="STKc_cPKC_beta"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.150">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000961">
<property type="entry name" value="AGC-kinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR000008">
<property type="entry name" value="C2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035892">
<property type="entry name" value="C2_domain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR034664">
<property type="entry name" value="cPKC-beta"/>
</dbReference>
<dbReference type="InterPro" id="IPR020454">
<property type="entry name" value="DAG/PE-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR002219">
<property type="entry name" value="PE/DAG-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR017892">
<property type="entry name" value="Pkinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR014375">
<property type="entry name" value="Protein_kinase_C_a/b/g"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00130">
<property type="entry name" value="C1_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00168">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00433">
<property type="entry name" value="Pkinase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000550">
<property type="entry name" value="PKC_alpha"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00360">
<property type="entry name" value="C2DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00008">
<property type="entry name" value="DAGPEDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00109">
<property type="entry name" value="C1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00239">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00133">
<property type="entry name" value="S_TK_X"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51285">
<property type="entry name" value="AGC_KINASE_CTER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50004">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00479">
<property type="entry name" value="ZF_DAG_PE_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50081">
<property type="entry name" value="ZF_DAG_PE_2"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="4">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Protein kinase C beta type" id="PRO_0000055687">
<location>
<begin position="2"/>
<end position="671"/>
</location>
</feature>
<feature type="domain" description="C2" evidence="6">
<location>
<begin position="158"/>
<end position="275"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="7">
<location>
<begin position="342"/>
<end position="600"/>
</location>
</feature>
<feature type="domain" description="AGC-kinase C-terminal" evidence="9">
<location>
<begin position="601"/>
<end position="671"/>
</location>
</feature>
<feature type="zinc finger region" description="Phorbol-ester/DAG-type 1" evidence="8">
<location>
<begin position="36"/>
<end position="86"/>
</location>
</feature>
<feature type="zinc finger region" description="Phorbol-ester/DAG-type 2" evidence="8">
<location>
<begin position="101"/>
<end position="151"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="7">
<location>
<begin position="348"/>
<end position="356"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="7 10">
<location>
<position position="466"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1; via carbonyl oxygen" evidence="14 19">
<location>
<position position="186"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1" evidence="14 19">
<location>
<position position="187"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2" evidence="14 19">
<location>
<position position="187"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2" evidence="14 19">
<location>
<position position="193"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1" evidence="14 19">
<location>
<position position="246"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2" evidence="14 19">
<location>
<position position="246"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; via carbonyl oxygen" evidence="14 19">
<location>
<position position="247"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1" evidence="14 19">
<location>
<position position="248"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2" evidence="14 19">
<location>
<position position="248"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 3" evidence="14 19">
<location>
<position position="248"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 3" evidence="14 19">
<location>
<position position="251"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 3; via carbonyl oxygen" evidence="14 19">
<location>
<position position="252"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1" evidence="14 19">
<location>
<position position="254"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 3" evidence="14 19">
<location>
<position position="254"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="7">
<location>
<position position="371"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="4">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="11"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="17">
<location>
<position position="16"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="17">
<location>
<position position="17"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="206"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="3">
<location>
<position position="250"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="17">
<location>
<position position="314"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="17">
<location>
<position position="324"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PDPK1" evidence="23 24 25">
<location>
<position position="500"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4">
<location>
<position position="504"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="17">
<location>
<position position="635"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="2 14 17 18">
<location>
<position position="642"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="14 18">
<location>
<position position="661"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SYK" evidence="5">
<location>
<position position="662"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Beta-II." id="VSP_004739" evidence="20 21">
<original>RDKRDTSNFDKEFTRQPVELTPTDKLFIMNLDQNEFAGFSYTNPEFVINV</original>
<variation>CGRNAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEFLKPEVKS</variation>
<location>
<begin position="622"/>
<end position="671"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="17">
<original>ST</original>
<variation>AA</variation>
<location>
<begin position="16"/>
<end position="17"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect; when associated with A-323." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect; when associated with A-313." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="50% increase of enzymatic activity." evidence="15">
<original>T</original>
<variation>E</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="mutagenesis site" description="50% decrease of enzymatic activity." evidence="15">
<original>T</original>
<variation>S</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzymatic activity." evidence="15">
<original>T</original>
<variation>V</variation>
<variation>D</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzymatic activity; when associated with T-643 change in subcellular location, loss of PMA-induced down-regulation and loss of enzymatic activity." evidence="16 17">
<original>T</original>
<variation>A</variation>
<location>
<position position="635"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzymatic activity; when associated with T-636 change in subcellular location, loss of PMA-induced down-regulation and loss of enzymatic activity." evidence="16 17">
<original>T</original>
<variation>A</variation>
<location>
<position position="642"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA41868." ref="3" evidence="22">
<original>A</original>
<variation>P</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA41875." ref="1" evidence="22">
<original>I</original>
<variation>V</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA41875." ref="1" evidence="22">
<original>N</original>
<variation>S</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA41875." ref="1" evidence="22">
<original>K</original>
<variation>R</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA41875." ref="1" evidence="22">
<original>S</original>
<variation>G</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA41875." ref="1" evidence="22">
<original>I</original>
<variation>V</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA41875." ref="1" evidence="22">
<original>RE</original>
<variation>GG</variation>
<location>
<begin position="170"/>
<end position="171"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA41875." ref="1" evidence="22">
<original>I</original>
<variation>V</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA41868." ref="3" evidence="22">
<original>G</original>
<variation>E</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA28035/CAA28036." ref="2" evidence="22">
<original>V</original>
<variation>M</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA41865." ref="1" evidence="22">
<location>
<position position="628"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA41865." ref="1" evidence="22">
<location>
<position position="640"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="161"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="194"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="222"/>
<end position="230"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="234"/>
<end position="237"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="239"/>
<end position="246"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="249"/>
<end position="251"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="254"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="263"/>
<end position="266"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="271"/>
<end position="276"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="280"/>
<end position="283"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2">
<location sequence="P68403-2">
<position position="641"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location sequence="P68403-2">
<position position="654"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location sequence="P68403-2">
<position position="660"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location sequence="P68403-2">
<position position="664"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1A25"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22673903"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P05771"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P68404"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00041"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00226"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00618"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10938109"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11714718"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19176525"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21215369"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7961692"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8034726"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8327493"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8749392"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9817842"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2428667"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3755379"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<evidence key="23" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21215369"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7961692"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="8749392"/>
</source>
</evidence>
<sequence length="671" mass="76751" checksum="A1935030F758513C" modified="2007-01-23" version="3">MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPASDDPRSKHKFKIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKARDKRDTSNFDKEFTRQPVELTPTDKLFIMNLDQNEFAGFSYTNPEFVINV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

